The financial sector is looking dangerous for investors right now. Here's what to know and how to play it right now.
For growth-focused biotech investors, Vaxcyte is no longer just a science story.
Michael Burry is questioning the AI spending spree by the tech giants. Should investors be trimming their positions on these popular names now?
Live and feeder cattle futures hit five- and four-week lows on Friday. Lean hogs stay steady, though.
CrowdStrike is due to report its Q4 results amid worries about potentially steep competition from AI vendors.
From moving averages to RSI, here's a streamlined charting toolkit to help options traders identify prime entry and exit points for trading.
With wars becoming the new normal, Lockheed Martin and Agnico Eagle Mines look like two stocks worth having in the portfolio.
Sustained member growth, improved monetization, accelerated fee-based revenue, and strengthened profitability will likely drive SOFI stock.
Although Advanced Micro Devices has benefited handsomely from the AI boon, sophisticated players appear to be hedging their bets on AMD stock.
Intuit is facing major long-term threats from AI and anxious investors. Its valuation is also not especially low.
